Eisai Completes Rolling Submission to US FDA for LEQEMBI®[...]
10/31/2024 | Press release | Distributed by Public on 10/31/2024 14:20
Please select the service you want to use:
Smartlinks | Supernus Pharmaceuticals Inc. | News | Health | Science | Research | Company News | Business Announcement | Products and Services | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact